ZA946321B - Antipsychotic method - Google Patents

Antipsychotic method

Info

Publication number
ZA946321B
ZA946321B ZA946321A ZA946321A ZA946321B ZA 946321 B ZA946321 B ZA 946321B ZA 946321 A ZA946321 A ZA 946321A ZA 946321 A ZA946321 A ZA 946321A ZA 946321 B ZA946321 B ZA 946321B
Authority
ZA
South Africa
Prior art keywords
antipsychotic method
antipsychotic
schizophrenia
susceptible
treating
Prior art date
Application number
ZA946321A
Other languages
English (en)
Inventor
Franklin Porter Bymaster
Harlan E Shannon
Per Sauerberg
Preben H Olesen
John Stanley Ward
Charles H Mitch
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA946321B publication Critical patent/ZA946321B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Epoxy Resins (AREA)
ZA946321A 1993-08-19 1994-08-19 Antipsychotic method ZA946321B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10928593A 1993-08-19 1993-08-19

Publications (1)

Publication Number Publication Date
ZA946321B true ZA946321B (en) 1996-02-19

Family

ID=22326851

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946321A ZA946321B (en) 1993-08-19 1994-08-19 Antipsychotic method

Country Status (23)

Country Link
US (3) US5679686A (zh)
EP (1) EP0714394B1 (zh)
JP (1) JP3474575B2 (zh)
KR (1) KR960703908A (zh)
CN (1) CN1040979C (zh)
AT (1) ATE202353T1 (zh)
CA (1) CA2169838C (zh)
CZ (1) CZ42796A3 (zh)
DE (1) DE69427537T2 (zh)
DK (1) DK0714394T3 (zh)
ES (1) ES2160127T3 (zh)
FI (1) FI960748A (zh)
GR (1) GR3036587T3 (zh)
HU (1) HU222116B1 (zh)
IL (1) IL110727A (zh)
NO (1) NO310597B1 (zh)
NZ (2) NZ271313A (zh)
PT (1) PT714394E (zh)
SG (1) SG55072A1 (zh)
TW (1) TW442285B (zh)
UA (1) UA43347C2 (zh)
WO (1) WO1995005379A1 (zh)
ZA (1) ZA946321B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA43347C2 (uk) * 1993-08-19 2001-12-17 Ново Нордіск А/С Спосіб лікування психічних захворювань
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5821370A (en) * 1994-10-24 1998-10-13 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
PE17897A1 (es) * 1995-02-17 1997-06-12 Lilly Co Eli Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
US5763457A (en) * 1995-11-13 1998-06-09 Eli Lilly And Company Method for treating anxiety
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
AU1128297A (en) * 1995-12-06 1997-06-27 Eli Lilly And Company Composition for treating pain
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
JP2002503224A (ja) * 1997-04-11 2002-01-29 エリ リリー アンド カンパニー 疼痛を処置するための組成物
JP2001520653A (ja) * 1997-04-11 2001-10-30 エリ リリー アンド カンパニー 精神***病の治療法
US20040023951A1 (en) * 2001-06-18 2004-02-05 Bymaster Franklin Porter Combination therapy for treatment of psychoses
AU2008326360A1 (en) * 2007-11-21 2009-05-28 Abbott Laboratories Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
US20110294835A1 (en) 2008-05-15 2011-12-01 The Board Of Trustees Of The University Of Illinois Muscarinic Agonists as Cognitive Enhancers
WO2012149524A1 (en) 2011-04-29 2012-11-01 The University Of Toledo Muscarinic agonists as enhancers of working memory and cognitive flexibility

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261763B1 (en) * 1986-06-27 1994-02-09 Beecham Group Plc Novel bridged bicyclic N-heterocycles
US4977176A (en) * 1987-01-31 1990-12-11 Sandoz Ltd. Pilocarpine compounds which are used as pharmaceutical agents
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
UA43347C2 (uk) * 1993-08-19 2001-12-17 Ново Нордіск А/С Спосіб лікування психічних захворювань

Also Published As

Publication number Publication date
DE69427537D1 (de) 2001-07-26
EP0714394B1 (en) 2001-06-20
WO1995005379A1 (en) 1995-02-23
US5679686A (en) 1997-10-21
CA2169838C (en) 2002-06-11
ATE202353T1 (de) 2001-07-15
DE69427537T2 (de) 2002-04-04
KR960703908A (ko) 1996-08-31
NZ336596A (en) 2001-02-23
HU222116B1 (hu) 2003-04-28
ES2160127T3 (es) 2001-11-01
SG55072A1 (en) 1998-12-21
AU7490494A (en) 1995-03-14
IL110727A0 (en) 1994-11-11
CA2169838A1 (en) 1995-02-23
AU697529B2 (en) 1998-10-08
UA43347C2 (uk) 2001-12-17
DK0714394T3 (da) 2001-10-01
FI960748A0 (fi) 1996-02-19
HUT73854A (en) 1996-09-30
US5677313A (en) 1997-10-14
HU9600363D0 (en) 1996-04-29
FI960748A (fi) 1996-04-18
TW442285B (en) 2001-06-23
CN1133044A (zh) 1996-10-09
IL110727A (en) 1998-08-16
NO960620D0 (no) 1996-02-16
NO310597B1 (no) 2001-07-30
CN1040979C (zh) 1998-12-02
JPH09501659A (ja) 1997-02-18
US5968926A (en) 1999-10-19
NO960620L (no) 1996-04-18
EP0714394A1 (en) 1996-06-05
PT714394E (pt) 2001-12-28
GR3036587T3 (en) 2001-12-31
CZ42796A3 (en) 1996-12-11
NZ271313A (en) 1999-09-29
JP3474575B2 (ja) 2003-12-08

Similar Documents

Publication Publication Date Title
SG55072A1 (en) Antipsychotic method
GB2275264B (en) Waste treatment process employing oxidation
EP0814814A4 (en) METHODS OF TREATING THROMBOSIS
AU1623295A (en) Ga- and/or In-containing AsGe sulfide glasses
HU9600364D0 (en) Antipsychotic method
GR3031149T3 (en) Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines.
AU1792288A (en) Method for treating schizophrenia
HUT73647A (en) Process for refining cycclodextrin
IL128028A0 (en) Treatment of psychotic disorders
DE69419598D1 (de) Abstichverfahren für hochofen
SG44613A1 (en) Process for the hydroxycarbonylation of butadiene
AU1097892A (en) Process and installation for the treatment of steel-mill slag
GB9501401D0 (en) Method for treating industrial effluent
ZA946358B (en) derivatives Process for the manufacture of phenoxyphenoxyalkyl
GB2279070B (en) Process for the treatment of sewage
GB2279887B (en) Sewage treatment process
LTIP719A (en) Process for the production of chees
HK1000839A1 (en) Process for the production of polyurethane lens
JO1770B1 (en) New formulations mainly composed of derivatives of sleepjestrol and the methods necessary to produce them
EP0678495A3 (de) Verfahren zur Reinigung von Perfluoralkylbromiden oder Perfluoralkylendibromiden.
GB9321433D0 (en) Treatment of inflammatory dermatoses
HU9200787D0 (en) Process for the production of fish-foods from protein waste